Compounds which potentiate AMPA receptor and uses thereof in medicine
US7642256B2 · kind B2 · utility
2Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2008 |
| Grant date | Jan 5, 2010 |
| Priority date | — |
| Expiry date | Dec 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and salts are provided:along with pharmaceutical compositions, uses in treating a disease or condition mediated by a reduction or imbalance in glutamate receptor function such as schizophrenia or cognition impairment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.